Drugs / Carboxymethyl-β-Glucan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03349619 | Mar → Jul 2018 | allergic rhinitis | Istituto per la Ricerca e l'Innovazione Biomedica | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carboxymethyl-β-Glucan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03349619 ↗ |